Sarepta Therapeutics Inc. (NASDAQ: SRPT) announced it will voluntarily and temporarily pause all shipments of ELEVIDYS for Duchenne muscular dystrophy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE